Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Part of paid clinical trials in Aliso Viejo, California.

Sponsor
Supernus Pharmaceuticals, Inc.
Study ID
NCT07219927
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observational study — OTHER
    Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM)

Study Details

Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease

Key Dates

Start date
Mar 31, 2025
Status verified
Oct 2025
Primary completion
Aug 1, 2027
Completion
Aug 1, 2027

Study Design

Enrollment
120 participants (estimated)

Primary Outcome Measure

Titration Duration and Time to Optimized Dose [ Time Frame: Approximately 52-60 weeks ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Parkinson's Disease and Movement Disorders Center - Orange County (South)Aliso ViejoCalifornia92656
Mindy Bixby, D.O.
Mindy Bixby, D.O. (PRINCIPAL_INVESTIGATOR)
Parkinson's Disease and Movement Disorders Center - Orange County (North)IrvineCalifornia92618
Sandeep Thakkar, D.O.
Sandeep Thakkar, D.O. (PRINCIPAL_INVESTIGATOR)
Parkinson's Research Centers of America - Palo AltoPalo AltoCalifornia94301
Salima Brillman, MD
Salima Brillman, MD (PRINCIPAL_INVESTIGATOR)
Parkinson's Disease & Movement Disorders Center of Boca RatonBoca RatonFlorida33486
Stuart Isaacson, MD
Stuart Isaacson, MD (PRINCIPAL_INVESTIGATOR)
Parkinson's Disease and Movement Disorders Center - Long IslandCommackNew York11725
David Kreitzman, M.D.
David Kreitzman, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Aliso Viejo, CA

Related Studies